732 related articles for article (PubMed ID: 19588360)
21. Adjuvant chemotherapy for advanced endometrial cancer.
Galaal K; Al Moundhri M; Bryant A; Lopes AD; Lawrie TA
Cochrane Database Syst Rev; 2014 May; 2014(5):CD010681. PubMed ID: 24832785
[TBL] [Abstract][Full Text] [Related]
22. Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm trial.
Trimbos JB; Vergote I; Bolis G; Vermorken JB; Mangioni C; Madronal C; Franchi M; Tateo S; Zanetta G; Scarfone G; Giurgea L; Timmers P; Coens C; Pecorelli S;
J Natl Cancer Inst; 2003 Jan; 95(2):113-25. PubMed ID: 12529344
[TBL] [Abstract][Full Text] [Related]
23. Adjuvant chemotherapy after concurrent chemoradiation for locally advanced cervical cancer.
Tangjitgamol S; Katanyoo K; Laopaiboon M; Lumbiganon P; Manusirivithaya S; Supawattanabodee B
Cochrane Database Syst Rev; 2014 Dec; 2014(12):CD010401. PubMed ID: 25470408
[TBL] [Abstract][Full Text] [Related]
24. Interval debulking surgery for advanced epithelial ovarian cancer.
Tangjitgamol S; Manusirivithaya S; Laopaiboon M; Lumbiganon P
Cochrane Database Syst Rev; 2008 Oct; (4):CD006014. PubMed ID: 18843699
[TBL] [Abstract][Full Text] [Related]
25. Platinum-containing regimens for triple-negative metastatic breast cancer.
Egger SJ; Chan MMK; Luo Q; Wilcken N
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD013750. PubMed ID: 33084020
[TBL] [Abstract][Full Text] [Related]
26. Interventions for the treatment of borderline ovarian tumours.
Faluyi O; Mackean M; Gourley C; Bryant A; Dickinson HO
Cochrane Database Syst Rev; 2010 Sep; 2010(9):CD007696. PubMed ID: 20824864
[TBL] [Abstract][Full Text] [Related]
27. Luteinising hormone releasing hormone (LHRH) agonists for the treatment of relapsed epithelial ovarian cancer.
Wuntakal R; Seshadri S; Montes A; Lane G
Cochrane Database Syst Rev; 2016 Jun; 2016(6):CD011322. PubMed ID: 27356090
[TBL] [Abstract][Full Text] [Related]
28. Interferon after surgery for women with advanced (Stage II-IV) epithelial ovarian cancer.
Lawal AO; Musekiwa A; Grobler L
Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD009620. PubMed ID: 23740789
[TBL] [Abstract][Full Text] [Related]
29. A systematic overview of chemotherapy effects in ovarian cancer.
Högberg T; Glimelius B; Nygren P;
Acta Oncol; 2001; 40(2-3):340-60. PubMed ID: 11441940
[TBL] [Abstract][Full Text] [Related]
30. Poly(ADP-ribose) polymerase (PARP) inhibitors for the treatment of ovarian cancer.
Wiggans AJ; Cass GK; Bryant A; Lawrie TA; Morrison J
Cochrane Database Syst Rev; 2015 May; 2015(5):CD007929. PubMed ID: 25991068
[TBL] [Abstract][Full Text] [Related]
31. Chemotherapy versus surgery for initial treatment in advanced ovarian epithelial cancer.
Morrison J; Swanton A; Collins S; Kehoe S
Cochrane Database Syst Rev; 2007 Oct; (4):CD005343. PubMed ID: 17943850
[TBL] [Abstract][Full Text] [Related]
32. Maintenance chemotherapy for ovarian cancer.
Mei L; Chen H; Wei DM; Fang F; Liu GJ; Xie HY; Wang X; Zou J; Han X; Feng D
Cochrane Database Syst Rev; 2010 Sep; (9):CD007414. PubMed ID: 20824860
[TBL] [Abstract][Full Text] [Related]
33. Optimal treatment of early-stage ovarian cancer.
Collinson F; Qian W; Fossati R; Lissoni A; Williams C; Parmar M; Ledermann J; Colombo N; Swart A;
Ann Oncol; 2014 Jun; 25(6):1165-71. PubMed ID: 24631948
[TBL] [Abstract][Full Text] [Related]
34. Postoperative adjuvant chemotherapy in rectal cancer operated for cure.
Petersen SH; Harling H; Kirkeby LT; Wille-Jørgensen P; Mocellin S
Cochrane Database Syst Rev; 2012 Mar; 2012(3):CD004078. PubMed ID: 22419291
[TBL] [Abstract][Full Text] [Related]
35. Angiogenesis inhibitors for the treatment of ovarian cancer.
Gaitskell K; Martinek I; Bryant A; Kehoe S; Nicum S; Morrison J
Cochrane Database Syst Rev; 2011 Sep; (9):CD007930. PubMed ID: 21901715
[TBL] [Abstract][Full Text] [Related]
36. International Collaborative Ovarian Neoplasm trial 1: a randomized trial of adjuvant chemotherapy in women with early-stage ovarian cancer.
Colombo N; Guthrie D; Chiari S; Parmar M; Qian W; Swart AM; Torri V; Williams C; Lissoni A; Bonazzi C;
J Natl Cancer Inst; 2003 Jan; 95(2):125-32. PubMed ID: 12529345
[TBL] [Abstract][Full Text] [Related]
37. Early stage ovarian cancer: the Italian contribution to clinical research. An update.
Favalli G; Odicino F; Torri V; Pecorelli S
Int J Gynecol Cancer; 2001; 11 Suppl 1():12-9. PubMed ID: 11488997
[TBL] [Abstract][Full Text] [Related]
38. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.
Forbes C; Shirran L; Bagnall AM; Duffy S; ter Riet G
Health Technol Assess; 2001; 5(28):1-110. PubMed ID: 11701100
[TBL] [Abstract][Full Text] [Related]
39. Chemotherapy for advanced ovarian cancer. Advanced Ovarian Cancer Trialists Group.
Stewart L;
Cochrane Database Syst Rev; 2000; (2):CD001418. PubMed ID: 10796788
[TBL] [Abstract][Full Text] [Related]
40. Lymphadenectomy for the management of endometrial cancer.
Frost JA; Webster KE; Bryant A; Morrison J
Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD007585. PubMed ID: 26387863
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
